These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1370662)

  • 1. Enhanced mucosal cytokine production in inflammatory bowel disease.
    Pullman WE; Elsbury S; Kobayashi M; Hapel AJ; Doe WF
    Gastroenterology; 1992 Feb; 102(2):529-37. PubMed ID: 1370662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons.
    Pullman WE; Doe WF
    Clin Exp Immunol; 1992 Apr; 88(1):132-7. PubMed ID: 1563100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
    Schreiber S; Raedler A; Conn AR; Rombeau JL; MacDermott RP
    Gut; 1992 Feb; 33(2):236-41. PubMed ID: 1541420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification.
    Isaacs KL; Sartor RB; Haskill S
    Gastroenterology; 1992 Nov; 103(5):1587-95. PubMed ID: 1426879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
    Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
    Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
    Schreiber S; Heinig T; Thiele HG; Raedler A
    Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.
    Schreiber S; MacDermott RP; Raedler A; Pinnau R; Bertovich MJ; Nash GS
    Gastroenterology; 1991 Oct; 101(4):1020-30. PubMed ID: 1889695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of epithelial cell growth factors by lamina propria mononuclear cells.
    Lowes JR; Priddle JD; Jewell DP
    Gut; 1992 Jan; 33(1):39-43. PubMed ID: 1740274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
    Liu Z; Geboes K; Colpaert S; D'Haens GR; Rutgeerts P; Ceuppens JL
    J Immunol; 2000 Apr; 164(7):3608-15. PubMed ID: 10725717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria.
    Carlsen HS; Yamanaka T; Scott H; Rugtveit J; Brandtzaeg P
    Inflamm Bowel Dis; 2006 Nov; 12(11):1013-24. PubMed ID: 17075342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
    Babyatsky MW; Rossiter G; Podolsky DK
    Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
    Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
    Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa.
    Grimm MC; Elsbury SK; Pavli P; Doe WF
    J Leukoc Biol; 1996 Jun; 59(6):804-12. PubMed ID: 8691064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.